Generic Substitution in The View of Pharmaceutical Scientists from Polish Medical Universities

• Autorzy: Damian Świeczkowski , Bartosz Pietrzak , Agnieszka Zimmermann
• Języki publikacji: EN

Abstrakty

EN

Generic substitution is a commonly observed phenomenon in pharmacy. It is promoted as part of the state drug policy and leads to a reduction in expenditure on drugs, facilitates the purchase of medicines by patients and improves compliance. So far researchers have focused on the evaluation of substitution by pharmacists, doctors or patients. The present study investigates the opinion of Pharmaceutical Faculties employees. The respondents acknowledge the importance of generic substitution; nevertheless they do not have a clear opinion on the effectiveness and safety of generic products. The respondents' experience may have had a significant impact their opinion, especially of those working in the community pharmacies. The studies is part of a broader framework of the national debate on generic substitution. Undoubtedly the approach to generic substitution is one of the contemporary challenges of the pharmaceutical law(original abstract)

Słowa kluczowe

EN

Pharmaceutical market; Pharmaceutical law; Medications; Drugstores

PL

Rynek farmaceutyczny; Prawo farmaceutyczne; Leki; Apteki

• Czasopismo: Journal of Health Policy and Outcomes Research
• Rocznik: 2014
• Numer: nr 2
• Strony: 50--57

Twórcy

autor

Damian Świeczkowski

• Studenckie Koło Prawa Farmaceutycznego, Gdański Uniwersytet Medyczny

autor

Bartosz Pietrzak

• Studenckie Koło Prawa Farmaceutycznego, Gdański Uniwersytet Medyczny

autor

Agnieszka Zimmermann

• Gdański Uniwersytet Medyczny

Bibliografia

• Posner J., Griffin J., Br J Clin., Generic Substitution, Pharmacol. 2011; 72(5): 321-322
• Act on the Reimbursement of Medicines, Foodstuffs Intended for Particular Nutritional Uses and Medical Devices, Poland, 2012
• The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. ​Available from: http://en.urpl.gov.pl; [Accessed: 14.12.2014]
• Hakonsen H. et all, Generic substitution: an additional challenge for adherence in hypertensive patients?. Curr Med Res Opin. 2009, 25(10): 2515 - 2521
• Durdeon M., Hughes D., Generic and therapeutic substitutions in the UK: are they a good thing?. Br J Clin Pharmacol 2010, 70(3): 335-341
• Wpływ ustawy o refundacji leków na dostęp pacjentów do farmakoterapii (..) Ocena skutków regulacji. Raport Infarma, Warszawa 2014
• Handoo S., Arora W., Khera D., A comprehensive study on regulatory requirements for development and filing of generic drugs globally. Int J Pharm Investig, 2012; 2(3): 99 - 104
• Stupans I., McKinnon R., Generic substitution in the treatment of epilepsy: patient attitudes and perceptions. Epilepsy Behav. 2013; 26(1): 64-66
• Hakonsen H., Eilertsen M. et all, Generic substitution: an additional challenge for adherence in hypertensive patients?. Curr Med Res Opin. 2009; 25(10): 2515 - 2521
• Gill L., Helkkula A., Cobelli N., White L., How do customers and pharmacists experience generic substitution?, International Journal of Pharmaceutical and Healthcare Marketing 2010; 4(4): 375 - 395
• LeLourier J. et all, Clinical consequences of generic substitution of lamotrigine for patients with epilepsy, Contemporary Issues in Neurological Practice 2008; 2179 - 2186
• Koskinen H., Ahola E. et all, The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland. Health Economics Review 2014; 4(9)

Identyfikatory

DOI

10.7365/JHPOR.2014.2.6